Discover the detailed record of transactions filed by Wagner Kristie Ann, Vice-Présidente, Finances et Comptabilité Principale. Insider active across 1 companies, notably Entasis Therapeutics Holdings Inc.. Aggregated, 1 reports have been logged. The latest transaction was disclosed on 24 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Kristie Ann Wagner serves as Vice President, Principal Finance and Accounting Officer at Entasis Therapeutics Holdings Inc. She is responsible for overseeing financial and accounting operations. Kristie plays a key role in managing financial resources and ensuring compliance with accounting standards. Her expertise in finance is essential to support Entasis Therapeutics Holdings Inc.'s financial strategy.